Might AI Help Sharpen Dementia Diagnosis?
Dementia ResearcherCould AI sharpen dementia diagnosis? Research presented at AAIC shows how medical records might help GPs identify who needs specialist testing.
Research News
Researchfish Closure: What Researchers Need to Know
Researchfish is closing in July 2027. Here’s what NIHR and UKRI-funded researchers need to know about reporting, deadlines and what happens next.
Catch-up on recordings from the Salon Research Showcase
The Dementia Researcher Salon Research Showcase features weekly talks where researchers present studies and findings in dementia research. Watch on YouTube.
Charting Tau Modifications as Alzheimer’s Advances
Alz ForumNew research maps how tau changes as Alzheimer’s progresses, identifying soluble tau modifications that could offer new biomarkers of tangle burden.
ISTAART Launches Two New Professional Interest Areas
Alzheimer's AssociationISTAART launches two new PIAs on physical activity and post-traumatic neurodegeneration. Join now to connect, collaborate and shape dementia research.
AAIC 2026 London: Podcast Conference Highlights
Catch up on AAIC 2026 with four daily podcasts featuring 10 guests sharing the research, conversations and conference moments that caught their attention.
Brain’s Immune Cells Rein in Alzheimer’s Brain Circuits
Suppressing microglia worsened abnormal brain activity and seizures in an Alzheimer’s mouse model, revealing their role in keeping neural circuits stable.
Wellcome Moves Major Funding Schemes to Rolling Applications
Wellcome TrustWellcome is removing fixed deadlines from three major funding schemes, allowing researchers to submit applications whenever they are ready.
Tau Studies Point to New Alzheimer’s Tests and Treatments
The CELIA trial found diranersen reduced tau and showed signs of slowing decline, while separate research linked blood tau with future Alzheimer’s risk.
Blood Test May Predict Alzheimer’s Risk 10 Years Early
A blood test measuring p-tau217 may predict Alzheimer’s-related cognitive decline up to a decade before symptoms appear, AAIC 2026 research finds.
Alzheimer’s Blood Test Could Transform Diagnosis
New data suggest an Alzheimer’s blood test could help primary care doctors diagnose the disease with around 90% accuracy, matching specialists. #AAIC26
LiBBY Trial: THC/CBD Reduces End-of-Life Agitation
Phase 2 LiBBY trial results suggest a THC/CBD combination rapidly and significantly reduces agitation in hospice-eligible people with dementia. #AAIC26